A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
- Publisher
- BRITISH JOURNAL OF CANCER
- Language
- 영어
- ISSN
- 0007-0920
- Citation Volume
- 124
- Citation Number
- 4
- Citation Start Page
- 713
- Citation End Page
- 720
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.